These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 34471497)

  • 1. Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase - Design, synthesis and biological evaluation.
    Remya C; Dileep KV; Koti Reddy E; Mantosh K; Lakshmi K; Sarah Jacob R; Sajith AM; Jayadevi Variyar E; Anwar S; Zhang KYJ; Sadasivan C; Omkumar RV
    Comput Struct Biotechnol J; 2021; 19():4517-4537. PubMed ID: 34471497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design Synthesis and
    Remya RS; Ramalakshmi N; Nalini CN; Niraimathi V; Amuthalakshmi S
    Curr Comput Aided Drug Des; 2022; 18(4):271-292. PubMed ID: 35927818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer's disease.
    Rastegari A; Safavi M; Vafadarnejad F; Najafi Z; Hariri R; Bukhari SNA; Iraji A; Edraki N; Firuzi O; Saeedi M; Mahdavi M; Akbarzadeh T
    Mol Divers; 2022 Feb; 26(1):409-428. PubMed ID: 34273065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of Memantine and 6-Chlorotacrine as Novel Multi-Target Compound against Alzheimer's Disease.
    Kaniakova M; Nepovimova E; Kleteckova L; Skrenkova K; Holubova K; Chrienova Z; Hepnarova V; Kucera T; Kobrlova T; Vales K; Korabecny J; Soukup O; Horak M
    Curr Alzheimer Res; 2019; 16(9):821-833. PubMed ID: 30819076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrine derivatives and Alzheimer's disease.
    Tumiatti V; Minarini A; Bolognesi ML; Milelli A; Rosini M; Melchiorre C
    Curr Med Chem; 2010; 17(17):1825-38. PubMed ID: 20345341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Developments in Tacrine-based Hybrids as a Therapeutic Option for Alzheimer's Disease.
    Yamali C; Donmez S
    Mini Rev Med Chem; 2023; 23(7):869-880. PubMed ID: 36464869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
    Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment.
    Minarini A; Milelli A; Tumiatti V; Rosini M; Simoni E; Bolognesi ML; Andrisano V; Bartolini M; Motori E; Angeloni C; Hrelia S
    Neuropharmacology; 2012 Feb; 62(2):997-1003. PubMed ID: 22032870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-target potential of newly designed tacrine-derived cholinesterase inhibitors: Synthesis, computational and pharmacological study.
    Jevtić II; Suručić RV; Tovilović-Kovačević G; Zogović N; Kostić-Rajačić SV; Andrić DB; Penjišević JZ
    Bioorg Med Chem; 2024 Mar; 101():117649. PubMed ID: 38401458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Agents in Alzheimer's Disease Through a Multi-targetdirected Ligands Strategy: Recent Progress Based on Tacrine Core.
    Lin H; Li Q; Gu K; Zhu J; Jiang X; Chen Y; Sun H
    Curr Top Med Chem; 2017; 17(27):3000-3016. PubMed ID: 28714419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-cognitive effects of dual tacrine derivatives acting as cholinesterase inhibitors and NMDA receptor antagonists.
    Chvojkova M; Kolar D; Kovacova K; Cejkova L; Misiachna A; Hakenova K; Gorecki L; Horak M; Korabecny J; Soukup O; Vales K
    Biomed Pharmacother; 2024 Jul; 176():116821. PubMed ID: 38823278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease.
    Uliassi E; Bergamini C; Rizzardi N; Naldi M; Cores Á; Bartolini M; Carlos Menéndez J; Bolognesi ML
    Bioorg Med Chem; 2023 Aug; 91():117419. PubMed ID: 37487339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
    Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
    Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
    Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-Target Drug Design of Anti-Alzheimer's Disease based on Tacrine.
    Tian S; Huang Z; Meng Q; Liu Z
    Mini Rev Med Chem; 2021; 21(15):2039-2064. PubMed ID: 33583371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT
    Więckowska A; Kołaczkowski M; Bucki A; Godyń J; Marcinkowska M; Więckowski K; Zaręba P; Siwek A; Kazek G; Głuch-Lutwin M; Mierzejewski P; Bienkowski P; Sienkiewicz-Jarosz H; Knez D; Wichur T; Gobec S; Malawska B
    Eur J Med Chem; 2016 Nov; 124():63-81. PubMed ID: 27560283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors.
    Svobodova B; Mezeiova E; Hepnarova V; Hrabinova M; Muckova L; Kobrlova T; Jun D; Soukup O; Jimeno ML; Marco-Contelles J; Korabecny J
    Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31430943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimeric Tacrine(10)-hupyridone as a Multitarget-Directed Ligand To Treat Alzheimer's Disease.
    Xuan Z; Gu X; Yan S; Xie Y; Zhou Y; Zhang H; Jin H; Hu S; Mak MSH; Zhou D; Keung Tsim KW; Carlier PR; Han Y; Cui W
    ACS Chem Neurosci; 2021 Jul; 12(13):2462-2477. PubMed ID: 34156230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3.
    Oukoloff K; Coquelle N; Bartolini M; Naldi M; Le Guevel R; Bach S; Josselin B; Ruchaud S; Catto M; Pisani L; Denora N; Iacobazzi RM; Silman I; Sussman JL; Buron F; Colletier JP; Jean L; Routier S; Renard PY
    Eur J Med Chem; 2019 Apr; 168():58-77. PubMed ID: 30798053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.